Salipot, Rosemarie A.
HRN: 23-85-73 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/17/2023
CEFUROXIME 750MG (VIAL)
11/17/2023
11/18/2023
IV
1.5gm
Q8 3 Doses
S/P LSCS
Checking Final Appropriateness
Indication: Empiric Type of Infection: Skin & Soft TissueIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes